PRIYA KOS: Open Payments
NPI 1851373229 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,718 in 58 payments from 14 companies in 2025. Trend: 2023 $1,454 · 2024 $3,642 · 2025 $2,718
Food & beverage: $2,388Travel & lodging: $330
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 25 | $1,735 |
| ABIOMED | 2 | $197 |
| Alnylam Pharmaceuticals Inc. | 3 | $166 |
| Amgen Inc. | 7 | $147 |
| Novo Nordisk Inc | 4 | $103 |
| AstraZeneca Pharmaceuticals LP | 2 | $88 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Davol Inc. | 2 | $33 |
| PFIZER INC. | 2 | $29 |
Products named: WATCHMAN FLX, WATCHMAN Access System, AMVUTTRA, Wegovy, REPATHA, ELIQUIS, LOKELMA, LEQVIO.
Industry payments across NC — which companies pay providers there.
